Company / Current Assets
Solid Biosciences Inc. Current Assets History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$219.6M
FY2022
5-year range
$86.3M / $222.6M
FY2018-FY2022
Trend
-1.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $159M to $220M over the past 2 years.
Based on SEC 10-K filings.
$220M in FY2022 with a 3-year CAGR of +36.5%.
Improved from $159M to $220M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +36.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +36.5%, indicating consistent growth.
- In FY2022, current assets decreased 1.3% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $219.6M | -1.3% |
| FY2021 | $222.6M | +40.1% |
| FY2020 | $158.9M | +84.1% |
| FY2019 | $86.3M | -32.9% |
| FY2018 | $128.6M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026